Get to know Ben, a 40-year-old from New York who has TRD. His internal struggles led to feelings of worthlessness and isolation, affecting his daily life. Ben had tried multiple antidepressants before his psychiatrist recommended SPRAVATO®.
Meet Karen, a brave woman from the Latin community located in Chicago, who has TRD. Karen had tried multiple antidepressants before her psychiatrist recommended a different approach: SPRAVATO®. Learn more about Karen’s SPRAVATO® treatment story and her experience with TRD in this video.
Over 100,000 patients in the US have received treatment with SPRAVATO®
SPRAVATO® used alone demonstrated a rapid and superior improvement in depressive symptoms at 4 weeks (primary endpoint) and at 24 hours (key secondary endpoint) vs placebo
SPRAVATO® + oral antidepressant is proven to provide rapid and superior improvement in depressive symptoms at Day 2
Long-term safety results up to 5 years